Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis

S Bloom, S Kiilerich, M R Lassen, A Forbes, K Leiper, E Langholz, E J Irvine, C O'Morain, D Lowson, S Orm

Research output: Contribution to journalArticlepeer-review

65 Citations (Scopus)


Heparin has anti-inflammatory and immunomodulatory activity which may be of therapeutic benefit in the treatment of ulcerative colitis.
Original languageEnglish
Pages (from-to)871-878
Number of pages8
JournalAlimentary Pharmacology and Therapeutics
Issue number8
Publication statusPublished - 15 Apr 2004


  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Colitis, Ulcerative
  • Double-Blind Method
  • Female
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Humans
  • Male
  • Middle Aged
  • Patient Compliance
  • Prospective Studies
  • Treatment Outcome

Cite this